Business news

    ASX200 green; Zip Co surges on record Q3 results; Australia rejects Johnson & Johnson COVID-19 vaccine

    Article Image
    Highlights
    • ASX200 is up 0.7% at 6974.7 at 1:30pm AEST.
    • Zip Co surges on record Q3 results including 80% increase in revenue.
    • Johnson & Johnson COVID-19 vaccine too similar to AstraZeneca jab.

    The tech sector is leading the gains today driven by Zip Co surging 11% after announcing record third quarter results.

    The Australian market is trading 0.7% higher at 1:30pm AEST fuelled by gains in the tech sector and a rebound for the gold miners.

    Bitcoin is trading 1.15% higher at US$60,659.91 at 1:30pm AEST.

    Australian-based BNPL player Zip Co is surging 11% today after releasing record third quarter results showing an 80% increase in group quarterly revenue to $114.4 million and growth in active customers globally to 6.4 million, up 88% from the same period a year earlier.

    Johnson & Johnson?s single shot COVID-19 vaccine will no longer be part of Australia's vaccine rollout plan based on the J&J shot being based on similar technology to the AstraZeneca vaccine. Health Minister Greg Hunt said the similarities between the two jabs were the reason the federal government has decided against pursuing the J&J vaccine.

    And Airbnb is attempting to stop post-vaccine summer parties in the US by launching its ?Summer of Responsible Travel? plan aimed at offering increased support to hosts and adjusting its policies to prevent Airbnbs from being used as party houses.

    Disclaimer

    Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relates to your unique circumstances. Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of, or reliance on the information provided directly or indirectly by use of this platform.

    Publisher
    Grafa